Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
[This corrects the article DOI: 10.1371/journal.pone.0238091.].
Saved in:
| Main Authors: | Ross McQueenie, Hamish M E Foster, Bhautesh D Jani, Srinivasa Vittal Katikireddi, Naveed Sattar, Jill P Pell, Frederick K Ho, Claire L Niedzwiedz, Claire E Hastie, Jana Anderson, Patrick B Mark, Michael Sullivan, Catherine A O'Donnell, Frances S Mair, Barbara I Nicholl |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0251613&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term conditions, multimorbidity and colorectal cancer risk in the UK Biobank cohort
by: Neave ME Corcoran, et al.
Published: (2022-06-01) -
Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
by: Peter Hanlon, et al.
Published: (2022-03-01) -
Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study
by: Naveed Sattar, et al.
Published: (2020-11-01) -
Linkages between socioeconomic inequalities, pro-environmental behaviours, climate change concerns and experiences, and wellbeing outcomes in England
by: Jonathan R. Olsen, et al.
Published: (2025-12-01) -
Comorbidity versus multimorbidity: Why it matters
by: Christopher Harrison, et al.
Published: (2021-02-01)